Authors: Vinci, MaraAff1, Aff2, Aff3, Aff23, Burford, AnnaAff1, Aff2, Aff3, Molinari, ValeriaAff1, Aff2, Aff3, Kessler, KettyAff1, Aff2, Aff3, Popov, SergeyAff1, Aff2, Aff3, Aff4, Clarke, MatthewAff1, Aff2, Aff3, Taylor, Kathryn R.Aff1, Aff2, Aff3, Aff5, Pemberton, Helen N., Lord, Christopher J., Gutteridge, Alice, Forshew, Tim, Carvalho, DianaAff1, Aff2, Aff3, Marshall, Lynley V., Qin, Elizabeth Y., Ingram, Wendy J.Aff9, Aff10, Moore, Andrew S.Aff9, Aff10, Aff11, Ng, Ho-Keung, Trabelsi, Saoussen, H’mida-Ben Brahim, DorraAff13, Aff14, Entz-Werle, Natacha, Zacharoulis, StergiosAff8, Aff24, Vaidya, Sucheta, Mandeville, Henry C., Bridges, Leslie R., Martin, Andrew J., Al-Sarraj, Safa, Chandler, Christopher, Sunol, Mariona, Mora, Jaume, de Torres, Carmen, Cruz, Ofelia, Carcaboso, Angel M., Monje, Michelle, Mackay, AlanAff1, Aff2, Aff3, Jones, ChrisAff1, Aff2, Aff3
Superior Title: Nature Medicine. 24(8):1204-1215
Authors: Lord, Christopher J1, Ashworth, Alan1
Superior Title: Nature Medicine. Nov2013, Vol. 19 Issue 11, p1381-1388. 8p.
Subject Terms: *GENETIC mutation, *BRCA proteins, *TARGETED drug delivery, *ADENOSINE diphosphate, *TUMOR suppressor proteins, *CANCER treatment